SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceuticals Industries informs about outcome of committee meeting

26 May 2017 Evaluate

Sun Pharmaceuticals Industries has informed that the Allotment Committee of Directors at its meeting held on Friday, May 26, 2017, has allotted 3,000 equity shares of the Company of Re 1 each, on exercise of stock options under the Sun Employee Stock Option Scheme – 2015; 12,000 equity shares of the Company of Re 1 each, to Sun Pharma ESOP Trust for further allocation to the employees on exercise of stock options from time to time under Sun Employee Stock Option Plan-2015. Accordingly, post the above allotment the paid-up equity share capital of the Company is Rs 2,399,306,181 divided into 2,399,306,181 equity shares of Re1 each.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1847.30 12.90 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×